BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.
Zacks Investment Research on MSN
BDX secures CE mark for Revello stent to treat iliac artery disease
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...
Add Yahoo as a preferred source to see more of our stories on Google. PCOS affects between 10% and 13% of women worldwide. Image credit: Toey Andante via Shutterstock.com. (Toey Andante via ...
Boston Scientific announced today that its Farapulse pulsed-field ablation (PFA) system has received expanded CE mark ...
First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU This in vitro diagnostic (IVD) assay, which has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results